Cases & Deals

Abbott invests in medical device company with arrhythmia treatment focus

Clients Abbott Laboratories

Jones Day advised Abbott Laboratories, a leading global health care company, in connection with its purchase of Series D Convertible Preferred Shares in a private placement by a medical device company focused on advanced treatment of arrhythmia.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.